March 25, 2024

New PeerLINC Knowledge Hub will Leverage Local Expertise and Experience to Accelerate New, More Effective TB Cures Around the World

Hub will focus on supporting global use of new treatments that effectively treated drug-resistant TB in 98% of Filipino participants
January 31, 2024

Funding for TB and Neglected Diseases Backslides

Statement from TB Alliance on the alarming trend of reduced funding for PDPs
November 13, 2023

TB Alliance Applauds Macleods’ Launch of a Key Component of WHO-Recommended Drug-Resistant TB Treatment Regimen

Macleods becomes second pharmaceutical manufacturer to bring pretomanid supply to market and first since the World Health Organization issued updated DR-TB treatment guidelines
November 9, 2023

New Drug-Resistant TB Treatments Reach Patients in Pakistan as Association for Social Development Accelerates Pilot Implementation

Preliminary results show increased cure rates for hard-to-treat TB infections; leads to update in Pakistan’s treatment guidelines
November 7, 2023

New WHO Global TB Report Shows Recovery in Effort to Combat TB, But Stronger Investments are Needed to Help Reach UN Goals

Statement from Mel Spigelman, M.D., President and Chief Executive Officer, TB Alliance
September 29, 2023

World Leaders Cite the Benefit and Importance of New, Six-Month Drug-Resistant TB Treatment at United Nations High-Level Meeting on Tuberculosis

Member States Commit to Increased Investment in TB Research and to Ensure New Innovations Reach Those in Need